Trial site
Ki Health Partners, LLc, dba New England Institute for Clinical Research
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Migraine6 trials
- Alzheimer disease5 trials
- Lewy body dementia1 trial
- Mild cognitive impairment1 trial
- Phase
- Phase 35 trials
- Phase 23 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Completed5 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Pfizer5 trials
- Eli Lilly and Company4 trials
- Cognition Therapeutics1 trial
- H. Lundbeck A/S1 trial
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Migraine2 recruiting
- Alzheimer disease1 recruiting
- Lewy body dementia1 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Terminated
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026